AMBIT BIOSCIENCES CORP 4 SEC Filings

Filed On	Filing
22 Dec 2014	Form 4: Marchington Allan P, Director Returned 1,396,487 shares to the issuer ($20.9M) · Disposed of 15,085 Stock Option (right to buy) (Disposition to Issuer) ($128K) · Disposed of 136,650 Warrant (right to buy) (Disposition to Issuer) ($2.22M)
13 Nov 2014	Form 4: Parkinson David Ross, Director Disposed of 15,085 Stock Option (Right to Buy) (Disposition to Issuer) ($128K)
12 Nov 2014	Form 4: Hasnain Faheem, Director Disposed of 160,181 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 20,000 Restricted Stock Units (Disposition to Issuer) ($300K)
12 Nov 2014	Form 4: Hatfield Jeffrey S., Director Disposed of 14,000 Stock Option (Right to Buy) (Disposition to Issuer) ($116K)
12 Nov 2014	Form 4: Fuhrman Alan, Chief Financial Officer Returned 6,309 shares to the issuer ($94.6K) · Disposed of 213,646 Stock Option (Right to Buy) (Disposition to Issuer) ($1.31M) · Disposed of 27,517 Restricted Stock Units (Disposition to Issuer) ($413K)
12 Nov 2014	Form 4: Foletta Mark G, Director Disposed of 22,000 Stock Option (Right to Buy) (Disposition to Issuer) ($124K)
12 Nov 2014	Form 4: Martino Michael A, Chief Executive Officer Disposed of 589,682 Stock Option (Right to Buy) (Disposition to Issuer) ($4.6M) · Disposed of 253,871 Restricted Stock Units (Disposition to Issuer) ($3.81M)
12 Nov 2014	Form 4: North Annette, Senior VP and General Counsel Disposed of 106,000 Stock Option (Right to Buy) (Disposition to Issuer) ($379K) · Disposed of 63,502 Restricted Stock Units (Disposition to Issuer) ($953K)
12 Nov 2014	Form 4: Countouriotis Athena, Chief Medical Officer Disposed of 222,126 Stock Option (Right to Buy) (Disposition to Issuer) ($1.34M) · Disposed of 18,882 Restricted Stock Units (Disposition to Issuer) ($283K)
04 Sep 2014	Form 4: Elms Steve, Director Received 2,362 shares by exercise ($15.7K) · Acquired 2,362 Stock Options (Right to Buy) (In/At-money Exercise)
16 Jul 2014	Form 4: Hasnain Faheem, Director Granted 20,000 Restricted Stock Units
04 Jun 2014	Form 4: Hatfield Jeffrey S., Director Granted 14,000 Stock Option (Right to Buy)
19 May 2014	Form 4: North Annette, Senior VP & General Counsel Granted 63,502 Restricted Stock Units
19 May 2014	Form 4: Countouriotis Athena, Chief Medical Officer Granted 18,882 Restricted Stock Units
19 May 2014	Form 4: Fuhrman Alan, CFO Granted 27,517 Restricted Stock Units
19 May 2014	Form 4: Martino Michael A, Director Granted 253,871 Restricted Stock Units
16 May 2014	Form 4: Peimer Isai, Director Granted 8,000 Stock Option (right to buy)
16 May 2014	Form 4: Parkinson David Ross, Director Granted 8,000 Stock Option (right to buy)
16 May 2014	Form 4: Marchington Allan P, Director Granted 8,000 Stock Option (right to buy)
16 May 2014	Form 4: Foletta Mark G, Director Granted 8,000 Stock Option (right to buy)

Comments